Immuno Concepts, NA Ltd.

Immuno Concepts, NA Ltd. is a diagnostic assay manufacturer specializing in systemic rheumatic disease detection, founded in 1979. The company pioneered the conversion from rodent tissue to HEp-2 cells for anti-nuclear antibody (ANA) detection and developed HEp-2000®, a patented ANA substrate with enhanced sensitivity for autoantibodies to SS-A/Ro and other connective tissue disease markers. Product lines include indirect fluorescent antibody (IFA) assays, enzyme immunoassay (EIA/ELISA) systems branded as RELISA™, ColorZyme™ chemiluminescent substrates, and automated specimen processing platforms. The company recently achieved FDA clearance for its IgG Anti-nDNA Fluorescent Test System for use with the Image Navigator® automated imaging platform. Immuno Concepts serves clinical laboratories and rheumatology practices with diagnostic reagents and systems for autoimmune disease detection. The company manufactures and distributes diagnostic reagents meeting FDA and international regulatory standards for in vitro diagnostic use.